Mark Versavel active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Vzenium LLC | Founder | - | - |
| President | - | - |
Career history of Mark Versavel
Former positions of Mark Versavel
| Companies | Position | Start | End |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2023 | 30/09/2023 |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Chief Tech/Sci/R&D Officer | - | - |
| NEUROBO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/12/2019 | - |
| ALZHEON, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Mark Versavel
| University of Antwerp | Doctorate Degree |
| Humboldt-Universität zu Berlin | Doctorate Degree |
| University of Michigan | Masters Business Admin |
Statistics
International
| United States | 7 |
| Belgium | 2 |
| Germany | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 2 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA. | Health Technology |
| Vzenium LLC |
- Stock Market
- Insiders
- Mark Versavel
- Experience
